Alto Neuroscience, Stock Probability of Future Stock Price Finishing Under 0.04
| ANRO Stock | 4.31 0.22 5.38% |
Alto |
Alto Neuroscience, Target Price Odds to finish below 0.04
The tendency of Alto Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to 0.04 or more in 90 days |
| 4.31 | 90 days | 0.04 | about 1.02 |
Based on a normal probability distribution, the odds of Alto Neuroscience, to drop to 0.04 or more in 90 days from now is about 1.02 (This Alto Neuroscience, probability density function shows the probability of Alto Stock to fall within a particular range of prices over 90 days) . Probability of Alto Neuroscience, price to stay between 0.04 and its current price of 4.31 at the end of the 90-day period is about 8.75 .
Given the investment horizon of 90 days the stock has the beta coefficient of 4.06 . This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Alto Neuroscience, will likely underperform. Additionally Alto Neuroscience, has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Alto Neuroscience, Price Density |
| Price |
Predictive Modules for Alto Neuroscience,
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Alto Neuroscience,. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Alto Neuroscience, Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Alto Neuroscience, is not an exception. The market had few large corrections towards the Alto Neuroscience,'s value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Alto Neuroscience,, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Alto Neuroscience, within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -1 | |
β | Beta against Dow Jones | 4.06 | |
σ | Overall volatility | 4.18 | |
Ir | Information ratio | -0.06 |
Alto Neuroscience, Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Alto Neuroscience, for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Alto Neuroscience, can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Alto Neuroscience, generated a negative expected return over the last 90 days | |
| Alto Neuroscience, has high historical volatility and very poor performance | |
| Net Loss for the year was (36.3 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Alto Neuroscience, generates negative cash flow from operations | |
| Alto Neuroscience, has a frail financial position based on the latest SEC disclosures | |
| Over 75.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from thelincolnianonline.com: Board of Trustees of The Leland Stanford Junior University Sells 264,273 Shares of Alto Neuroscience, Inc. |
Alto Neuroscience, Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Alto Stock often depends not only on the future outlook of the current and potential Alto Neuroscience,'s investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Alto Neuroscience,'s indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 26.9 M | |
| Cash And Short Term Investments | 82.5 M |
Alto Neuroscience, Technical Analysis
Alto Neuroscience,'s future price can be derived by breaking down and analyzing its technical indicators over time. Alto Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Alto Neuroscience,. In general, you should focus on analyzing Alto Stock price patterns and their correlations with different microeconomic environments and drivers.
Alto Neuroscience, Predictive Forecast Models
Alto Neuroscience,'s time-series forecasting models is one of many Alto Neuroscience,'s stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Alto Neuroscience,'s historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Alto Neuroscience,
Checking the ongoing alerts about Alto Neuroscience, for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Alto Neuroscience, help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Alto Neuroscience, generated a negative expected return over the last 90 days | |
| Alto Neuroscience, has high historical volatility and very poor performance | |
| Net Loss for the year was (36.3 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Alto Neuroscience, generates negative cash flow from operations | |
| Alto Neuroscience, has a frail financial position based on the latest SEC disclosures | |
| Over 75.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from thelincolnianonline.com: Board of Trustees of The Leland Stanford Junior University Sells 264,273 Shares of Alto Neuroscience, Inc. |
Check out Alto Neuroscience, Backtesting, Alto Neuroscience, Valuation, Alto Neuroscience, Correlation, Alto Neuroscience, Hype Analysis, Alto Neuroscience, Volatility, Alto Neuroscience, History as well as Alto Neuroscience, Performance. To learn how to invest in Alto Stock, please use our How to Invest in Alto Neuroscience, guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alto Neuroscience,. If investors know Alto will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alto Neuroscience, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.85) |
The market value of Alto Neuroscience, is measured differently than its book value, which is the value of Alto that is recorded on the company's balance sheet. Investors also form their own opinion of Alto Neuroscience,'s value that differs from its market value or its book value, called intrinsic value, which is Alto Neuroscience,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alto Neuroscience,'s market value can be influenced by many factors that don't directly affect Alto Neuroscience,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alto Neuroscience,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Alto Neuroscience, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alto Neuroscience,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.